Literature DB >> 8097000

Viral dynamics in primary HIV-1 infection.

M Piatak, L C Yang, K C Luk, J D Lifson, M S Saag, S J Clark, J C Kappes, B H Hahn, G M Shaw.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8097000     DOI： 10.1016/0140-6736(93)92463-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Pilot studies for development of an HIV subtype panel for surveillance of global diversity.

Authors:  Mark Manak; Silvana Sina; Bharathi Anekella; Indira Hewlett; Eric Sanders-Buell; Viswanath Ragupathy; Jerome Kim; Marion Vermeulen; Susan L Stramer; Ester Sabino; Piotr Grabarczyk; Nelson Michael; Sheila Peel; Patricia Garrett; Sodsai Tovanabutra; Michael P Busch; Marco Schito
Journal:  AIDS Res Hum Retroviruses       Date:  2012-02-24       Impact factor: 2.205

2.  The cell tropism of human immunodeficiency virus type 1 determines the kinetics of plasma viremia in SCID mice reconstituted with human peripheral blood leukocytes.

Authors:  G R Picchio; R J Gulizia; K Wehrly; B Chesebro; D E Mosier
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

3.  Quantifying the impact of human immunodeficiency virus-1 escape from cytotoxic T-lymphocytes.

Authors:  Ulrich D Kadolsky; Becca Asquith
Journal:  PLoS Comput Biol       Date:  2010-11-04       Impact factor: 4.475

4.  Preclinical Proof-of-Concept, Analytical Development, and Commercial Scale Production of Lentiviral Vector in Adherent Cells.

Authors:  Hanna M Leinonen; Eevi M Lipponen; Anniina J Valkama; Heidi Hynynen; Igor Oruetxebarria; Vesa Turkki; Venla Olsson; Jere Kurkipuro; Haritha Samaranayake; Ann-Marie Määttä; Nigel R Parker; Seppo Ylä-Herttuala; Hanna P Lesch
Journal:  Mol Ther Methods Clin Dev       Date:  2019-08-29       Impact factor: 6.698

5.  Optimization of lentiviral vector production for scale-up in fixed-bed bioreactor.

Authors:  A J Valkama; H M Leinonen; E M Lipponen; V Turkki; J Malinen; T Heikura; S Ylä-Herttuala; H P Lesch
Journal:  Gene Ther       Date:  2017-10-05       Impact factor: 5.250
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.